According to miRagen Therapeutics's latest financial reports the company's current revenue is โน0.23 Billion. In 2019 the company made a revenue of โน0.40 Billion a decrease over the revenue in the year 2018 that were of โน0.76 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.